Publications by authors named "Frank Preugschat"

Claim this Profile
C
Complementary NAD replacement strategies fail to functionally protect dystrophin-deficient muscle.
David W Frederick, Alan V McDougal, Melisa Semenas, Johanna Vappiani, Andrea Nuzzo, Frank Preugschat

Skelet Muscle· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genetic Ablation of CD38 Protects against Western Diet-Induced Exercise Intolerance and Metabolic Inflexibility.
Shian-Huey Chiang, W Wallace Harrington, Guizhen Luo, Naphtali O Milliken, John C Ulrich, Frank Preugschat

PLoS One· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of 4-Amino-8-quinoline Carboxamides as Novel, Submicromolar Inhibitors of NAD-Hydrolyzing Enzyme CD38.
J David Becherer, Eric E Boros, Tiffany Y Carpenter, David J Cowan, David N Deaton, Frank Preugschat

J Med Chem· September 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery, Synthesis, and Biological Evaluation of Thiazoloquin(az)olin(on)es as Potent CD38 Inhibitors.
Curt D Haffner, J David Becherer, Eric E Boros, Rodolfo Cadilla, Tiffany Carpenter, Frank Preugschat

J Med Chem· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A pre-steady state and steady state kinetic analysis of the N-ribosyl hydrolase activity of hCD157.
Frank Preugschat, Luke H Carter, Eric E Boros, David J T Porter, Eugene L Stewart

Arch Biochem Biophys· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The base exchange reaction of NAD+ glycohydrolase: identification of novel heterocyclic alternative substrates.
Frank Preugschat, Ginger H Tomberlin, David J T Porter

Arch Biochem Biophys· November 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis and evaluation of novel heterocyclic inhibitors of GSK-3.
Terrence L Smalley, Andrew J Peat, Joyce A Boucheron, Scott Dickerson, Dulce Garrido, Frank Preugschat

Bioorg Med Chem Lett· April 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery and in vitro evaluation of potent kinase inhibitors: Pyrido[1',2':1,5]pyrazolo[3,4-d]pyrimidines.
Michael J Alberti, Elizabeth P Auten, Karen E Lackey, Octerloney B McDonald, Edgar R Wood, Frank Preugschat

Bioorg Med Chem Lett· August 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
N-Phenyl-4-pyrazolo[1,5-b]pyridazin-3-ylpyrimidin-2-amines as potent and selective inhibitors of glycogen synthase kinase 3 with good cellular efficacy.
Francis X Tavares, Joyce A Boucheron, Scott H Dickerson, Robert J Griffin, Frank Preugschat

J Med Chem· September 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel pyrazolopyrimidine derivatives as GSK-3 inhibitors.
Andrew J Peat, Joyce A Boucheron, Scott H Dickerson, Dulce Garrido, Wendy Mills, Frank Preugschat

Bioorg Med Chem Lett· May 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis